After more than 50 years of research, scientists still don't know exactly what causes autism. But the data make clear that ...

Analysis of more than 1 million people shows that mental-health disorders fall into five clusters, each of them linked to a ...

Researchers from ETH Zurich have succeeded in introducing large quantities of unnatural amino acids into bacteria, enabling ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual carrying the presenilin 2 (PSEN2) p.Asn141Ile mutation, a genetic variant ...

Rice University researchers have revealed novel sequence-structure-property relationships for customizing engineered living materials (ELMs), enabling more precise control over their structure and how ...

The cell and gene therapy CRO market presents growth opportunities driven by FDA-approved therapies, over 90 global approvals, and 3,500 trials across 16 therapeutic areas, primarily in North America.

Despite the importance of GoF modifications, they have sometimes faced misplaced concerns or opposition that could lead to their being overregulated or even banned.

Technologies needed for tracing engineered biothreats back to their sources are advancing rapidly. Here are some ...

Introduction: Effective CAR T cell infiltration into solid tumors remains a major barrier to therapy success. Despite their clinical potential, few studies have evaluated phenotypes of CAR T cells ...

KIT researchers succeeded for the first time in reducing the number of chromosomes in a plant using the CRISPR/Cas method – surprisingly without affecting its growth The CRISPR/Cas molecular scissors ...